MP Bharat Agro's 150% capacity expansion came with a 40% capex overrun
Record FY26 PAT of ₹150 cr and 60-70% FY27 growth guidance are overshadowed by three strategy reversals that raise questions about management's reliability on capex, trading, and working capital.
What's new
- Record FY26 PAT of ₹150 crore, up 161% YoY.
- Capacity expanding 150%+ to 9+ lakh MT by FY27.
- Maharashtra SSP plant online April 2026; DAP/NPK plant by October 2026.
- Backward integration includes green ammonia fixed-price contract from FY29.
Themes from the call
Demand
Fertilizer industry 5-6% CAGR, India imports 42% of NPK/DAP; MP Bharat targeting import substitution with new capacity.
Margins
Core manufacturing margins 13-15%, but trading mix dragged blended margins to 10%; management expects recovery as trading share shrinks.
Capital allocation
₹1,000+ cr capex (70% debt) for 150% capacity hike; 3-year debt payoff target with strong coverage, but overrun adds risk.
Guidance watch
- FY27 top-line growth 60-70% guided (Q&A); FY28 >100% contingent on full utilization. No specific FY27 margin target.
Risk flags
- Capex overrun of 40% (₹300+ cr) without prior warning; trading pivot depresses margins; negative operating cash flow despite record profits.
Key quotes
-
"Doubling our NPK capacity will significantly drive the top line. We expect a 60-70% top-line growth in the coming year."
— Management, Q&A on future outlook -
"If you look at our debt, most of it was utilized for our 150% plant capacity enhancement, which required over 1,000 crores."
— Management, June 2026 call
The brief
MP Bharat Agro's June 2026 concall was a mixed bag: record numbers on one side, strategy reversals on the other. The headline figure is a FY26 PAT of ₹150 crore, up 161% YoY, driven by 100% NPK and 98% SSP capacity utilization. Management guided 60-70% top-line growth in FY27 and >100% in FY28, powered by a 150% capacity expansion to 9+ lakh MT. But three inconsistencies from prior calls undercut the narrative. First, the capex guidance: in October 2025, management pegged the Sagar and Dhule expansion at ₹700 crore. Now it discloses the cost exceeded ₹1,000 crore — a 40% overrun with no explanation. Second, trading activity: originally described as limited internal activity, it became a major revenue driver, depressing consolidated margins to 10% from the guided 13-15% manufacturing margin. Third, working capital: management had promised improvement but delivered negative operating cash flow due to inventory build. The positives are real — backward integration, green ammonia hedge, and Maharashtra entry — but the credibility gap on numbers and strategy is hard to ignore. Investors must decide whether the capacity story outruns the governance concerns.
MP Bharat Agro's growth story is real, but three strategy flip-flops undermine trust in management's numbers.